Your browser doesn't support javascript.
loading
Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study.
Zeidman, Michael; Alberty-Oller, J Jaime; Ru, Meng; Pisapati, Kereeti V; Moshier, Erin; Ahn, Soojin; Mazumdar, Madhu; Port, Elisa; Schmidt, Hank.
Affiliation
  • Zeidman M; Mount Sinai Health System, New York, USA. mikezeidman@gmail.com.
  • Alberty-Oller JJ; Mount Sinai Health System, New York, USA.
  • Ru M; Mount Sinai Health System, New York, USA.
  • Pisapati KV; Mount Sinai Health System, New York, USA.
  • Moshier E; Mount Sinai Health System, New York, USA.
  • Ahn S; Mount Sinai Health System, New York, USA.
  • Mazumdar M; Mount Sinai Health System, New York, USA.
  • Port E; Mount Sinai Health System, New York, USA.
  • Schmidt H; Mount Sinai Health System, New York, USA.
Breast Cancer Res Treat ; 184(1): 203-212, 2020 Nov.
Article in En | MEDLINE | ID: mdl-32740807
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: United States Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2020 Document type: Article Affiliation country: United States Country of publication: Netherlands